Although concentrations of most inflammatory biomarkers were resolved in survivors of COVID-19, the concentration of hsCRP and percentage of elevated TNF-α in survivors of COVID-19 were still greater than those in healthy and risk factor-matched controls, indicating that a chronic low-grade inflammation could persist late after recovery from COVID-19. This evidence concerns the gene TNF and COVID-19.